Biotechnology

EV Biologics Starts Custom Cell Isolation with Lonza Cell Bio Services

July 28, 2021 9:00 AM

NASHVILLE, TN / ACCESSWIRE / July 28, 2021 / EV Biologics Corp, OTC PINK:YECO today announced that it has signed an agreement with Lonza Cell Bio Services to implement a custom cell isolation in preparation for a novel, clonal, master cell bank. These cells will also be used in optimization of the process for production of therapeutically active, native, extracellular vesicles and particles (EVP). Lonza Cell Bio Services is a leading provider of...

Read more

Green Planet Projects Major Increase in Revenues

July 28, 2021 9:00 AM

PHOENIX, AZ / ACCESSWIRE / July 28, 2021 / Green Planet Group, Inc. (OTC PINK:GNPG), an emerging leader in green technology, announced today that its wholly owned subsidiary, XenTx Lubricants' Nigerian international distributor, FirstHypo Tech Ltd, has obtained government required approvals to sell seven of the XenTx products in its country. The Federal Ministry of Trade and Investment issued the Trademark Acceptance Letters on July 11, 2021....

Read more

Pieris Pharmaceuticals to Host Second Quarter 2021 Investor Call and Provide Corporate Update on August 4, 2021

July 28, 2021 8:00 AM

BOSTON, MA / ACCESSWIRE / July 28, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced that it will host a second quarter 2021 investor call on Wednesday, August 4, 2021 at 8:00 AM EDT to discuss financial results and provide a corporate update. To...

Read more

ITOCO Welcomes Mr. Alberto Ramirez As the Leader of Its Technical Management Team, Carbon Credits

July 28, 2021 8:00 AM

TORONTO, ON / ACCESSWIRE / July 28, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to announce that Mr. Alberto Ramirez has joined the firm as leader of Technical Management Team, Carbon Credits and Capture. Mr. Ramirez is a Biologist and graduated from the National Autonomous University of Mexico. He came to Itoco from the World Resources Institute (WRI) - Mexico, where he is the Forest Carbon Coordinator. He was responsible for coordinating...

Read more

DehydraTECH-Enabled Consumer Products Now Available in Over 7,000 Stores

July 28, 2021 7:05 AM

Lexaria's technology empowers brands nationwide in stores including Albertsons, Hudson News, and many more KELOWNA, BC / ACCESSWIRE / July 28, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that its DehydraTECHTM technology has been embraced by consumer brands now available for sale in over 7,000 stores across the US. "Lexaria's...

Read more

Materna Medical Raises $10 Million in Series A2 Funding in Women's Health

July 27, 2021 12:21 PM

Growing novel OBGYN platform company that defines a $6B market in the most common pelvic conditions women face MOUNTAIN VIEW, CA / ACCESSWIRE / July 27, 2021 / Materna Medical (Materna), a clinical-stage medical device company, has announced the completion of a $10 million Series A2 financing round. The round was led by Wavemaker Three-Sixty Health (Wavemaker 360) with new investors including Kimera Limited, Women's Venture Capital Fund, Golden...

Read more

ITOCO Welcomes Mr. Rene A. Ibarra to its Technical Management Team, Carbon Credits

July 27, 2021 10:15 AM

TORONTO, ON / ACCESSWIRE / July 27, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to announce that Mr. Rene Ibarra has joined the firm's Technical Management Team, Carbon Credits and Capture. Previously, he has been accredited as a leading verifier by the Climate Action Reserve to verify Carbon Capture projects under the standard of the Mexico Forest Protocol since 2016, participating in the evaluation of 48 projects developed in the State of...

Read more

Apollo Endosurgery to Report Second Quarter Financial Results on August 3, 2021

July 27, 2021 8:00 AM

AUSTIN, TX / ACCESSWIRE / July 27, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the second quarter ended June 30, 2021 on Tuesday, August 3, 2021 after the market closes. In conjunction with the release, Apollo will host a conference...

Read more

Lexaria Completes Dosing in Human Clinical Study HYPER-H21-2

July 27, 2021 7:15 AM

Additionally, second patent award received in Japan KELOWNA, BC / ACCESSWIRE / July 27, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that dosing has been completed in its second human clinical study of 2021. Human clinical study HYPER-H21-2 consisted of 16 human volunteers who were pre- or mildly hypertensive and received three...

Read more

Lexaria Receives US$3,817,643 From Warrant Exercises

July 26, 2021 2:40 PM

KELOWNA, BC / ACCESSWIRE / July 26, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce the receipt of US$3,817,643 from the exercise of share purchase warrants (the "Warrants"). The Warrants were issued by the Company pursuant to its January 2021 public underwritten offering (the "Offering") whereby the shares and Warrants issued...

Read more

EV Biologics Unveils NFT Dividend Warrant

July 26, 2021 9:30 AM

NASHVILLE, TN / ACCESSWIRE / July 26, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend Warrant. The Company will distribute one (1) Warrant for every 100 shares of YECO common stock held. Each Warrant will be exercisable for one (1) NFT worth $300. Shareholders will have 90-days (October 28, 2021) to exercise their Warrants to receive their NFTs. YECO's shareholders of record on July 30, 2021 will...

Read more

Enzolytics Announces the Appointment of Steve Sharabura as President of its Wholly Owned Subsidiary RobustoMed, Inc (A/K/A ENZO SUB)

July 26, 2021 7:30 AM

COLLEGE STATION, TX / ACCESSWIRE / July 26, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) ("Enzolytics" and the "Company") announced today the appointment of Steve Sharabura as President of the Company's wholly owned subsidiary RobustoMed, Inc. (A/K/A ENZO SUB) based in Atlanta, GA. RobustoMed will be initiating a new business model focused on developing international partnership opportunities for medical development stage drug and product companies....

Read more

Xenetic Biosciences, Inc. Announces $12.5 Million Private Placement Priced at a Premium to Market

July 26, 2021 7:00 AM

FRAMINGHAM, MA / ACCESSWIRE / July 26, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase of 4,629,630 shares of its common...

Read more

Applied UV Declares Monthly Preferred Stock Dividend

July 23, 2021 8:00 AM

MOUNT VERNON, NY / ACCESSWIRE / July 23, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced its Board of Directors has authorized the cash dividend to holders of Applied...

Read more

RedHill Settles Movantik(R) Apotex Patent Litigation

July 22, 2021 9:45 AM

RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with Apotex TEL AVIV, ISRAEL and RALEIGH, NC / ACCESSWIRE / July 22, 2021 / RedHill Biopharma Ltd. (Nasdaq:RDHL) ('RedHill' or the 'Company'), a specialty biopharmaceutical company, today announced that RedHill Biopharma Inc., AstraZeneca AB and AstraZeneca Pharmaceuticals LP ('AstraZeneca') and Nektar Therapeutics have entered into a settlement and license agreement with...

Read more

EV Biologics Signs LOI with Lonza Cell & Gene Therapy

July 22, 2021 9:30 AM

NASHVILLE, TN / ACCESSWIRE / July 22, 2021 / EV Biologics Corp., (OTC PINK:YECO) today announced that it has signed a Letter of Intent (LOI) with Lonza Cell & Gene Therapy for Process Development and Gap Analysis for biomanufacturing of a novel therapeutic composition, comprising extracellular vesicles (EVs) and particles, as well as other secreted factors derived from selected stem/progenitor cells, such as mesenchymal stromal cells (MSCs)....

Read more

Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy

July 22, 2021 7:05 AM

All objectives evaluating DehydraTECH™ drug delivery platform successfully achieved KELOWNA, BC / ACCESSWIRE / July 22, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to review its successful 2021 antiviral drug program to date and summarize expected next steps. Lexaria's objectives in its 2021 antiviral drug examination program thus far have been...

Read more

Pressure BioSciences Announces Major Business Expansion, Establishing Eco-Friendly Agrochemicals Subsidiary and Initiating Plans to Drive Accretive 2021 Revenue

July 21, 2021 9:25 AM

Significant Order for Environmentally Friendly Agrochemical Material Placed to Fulfill Initial Demand; Subsidiary will House Announced Asset Acquisition from Global Agrochemicals Innovator SOUTH EASTON, MA / ACCESSWIRE / July 21, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the...

Read more

M2Bio Sciences Food and Beverage Launches CBD Sachets

July 21, 2021 9:15 AM

CAPE TOWN, SA / ACCESSWIRE / July 21, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update: M2Bio Sciences Food & Beverage is pleased to announce the launch of the M2Bio 10mg CBD Dissolvable Powder Sachets. The sachets are the latest innovation from the Company's M2Bio brand...

Read more

Black Bird Biotech to Seek EPA Approval of MiteXstream(TM) Ready-to-Use Formulation

July 21, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / July 21, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that it will seek EPA approval of the Ready-to-Use formulation of MiteXstreamTM, as a necessary first step to its capitalizing on the lucrative home gardening market. "We see MiteXstreamTM as the perfect solution for home gardeners who battle a wide array of pests, molds and mildews,...

Read more